You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-23. Polydrug use among all clients entering outpatient treatment, for countries supplying data for 2006: opioids, cocaine, cannabis or other stimulants as primary drug type combined with a secondary drug type [see all tables in this series...]

Part (iii) All clients with cocaine as primary drug type: number of episodes reporting the stated drug as secondary

Country	Opioids	Cocaine	Other stimulants	Hypnotics/sedatives	Hallucinogens	Volatile substances	Cannabis	Alcohol	Others
Czech Republic	0	0	2	0	0	0	0	0	4
Denmark	31	0	141	68	26	4	158	167	845
Germany	519	2647	864	187	237	15	1139	791	31
Ireland	48	8	124	47	4	1	184	178	1
Greece	27	1	18	4	15	0	49	3	181
Spain	742	10	1418	571	214	19	5815	7960	19808
France	270	47	140	50	22	3	371	224	1662
Italy	1227	66	584	193	146	20	2537	1947	8975
Cyprus	12	1	25	0	4	0	34	7	124
Latvia	1	0	0	0	0	0	0	0	2
Luxembourg	26	0	6	6	2	0	20	2	62
Malta	22	0	22	10	6	0	34	6	100
Netherlands	366	18	198	39	9	1	591	908	2242
Austria	57	1	63	23	14	1	61	49	401
Slovakia	2	0	3	0	0	0	2	1	0
Finland	0	0	1	0	0	0	1	2	0
Sweden	5	1	23	8	1	0	11	16	69
United Kingdom	2492	675	1273	419	66	15	3404	3342	16453
Total	5847	3475	4905	1625	766	79	14411	15603	50960

Notes:

Data on secondary drug use are only collected among all treatment clients and not separately for new treatment clients.

‘Opioids’ include: heroin, methadone, other opioids; ‘Cocaine’ includes: cocaine HCl, crack cocaine; ‘Stimulants’ include: amphetamines, MDMA and derivates, other stimulants: ‘Cannabis’ can include herb or resin. For each client up to four secondary drugs can be reported.

A number of the clients report using the same drug both as primary and secondary drug, particularly for cannabis. Clients may report using different sub-types of the same substance, as defined in the TDI Protocol for the drugs categories.

See also 'General notes for interpreting data’ on the Explanatory notes and help page.

Sources:

Reitox national reports 2007.

Download this data in Excel (.xls) format

(see the help page for information about formats etc.)